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Three-dimensional (3D) in vitro models span the gap between two-dimensional cell cultures 
and whole-animal systems. By mimicking features of the in vivo environment and taking 
advantage of the same tools used to study cells in traditional cell culture, 3D models 
provide unique perspectives on the behavior of stem cells, developing tissues and organs, 
and tumors. These models may help to accelerate translational research in cancer biology 
and tissue engineering.Tissues and organs are three dimensional (3D). How-
ever, our ability to understand their formation, function, 
and pathology has often depended on two-dimen-
sional (2D) cell culture studies or on animal model sys-
tems. Studies in standard cell culture have produced 
many important conceptual advances. Nevertheless, 
cells grown on flat 2D tissue culture substrates can 
differ considerably in their morphology, cell-cell and 
cell-matrix interactions, and differentiation from those 
growing in more physiological 3D environments (Birg-
ersdotter et al., 2005; Cukierman et al., 2002; Griffith 
and Swartz, 2006; Nelson and Bissell, 2006). At the 
other end of the experimental continuum, animal mod-
els frequently provide definitive tests of the impor-
tance of specific molecules and processes. However, 
there also can be puzzling discrepancies between 
conclusions from gene ablation studies and studies 
using chemical genetics approaches to interfere with 
the function of specific proteins (Knight and Shokat, 
2007). In addition, animal models may not adequately 
reproduce features of, for example, human tumors, 
drug therapeutic responses, autoimmune diseases, 
and stem cell differentiation. In vitro 3D tissue models 
provide a third approach that bridges the gap between 
traditional cell culture and animal models (Griffith and 
Swartz, 2006; Rangarajan et al., 2004).
These in vitro 3D tissue models fulfill a need for 
reductionist approaches to understand in vivo molec-
ular mechanisms. Moreover, the powerful tools of cell 
and molecular biology currently used in traditional cell 
cultures can often by applied to 3D tissue models. 
Increased use of 3D models that mimic specific tis-
sues should promote advances in tissue engineering 
and could also facilitate the development and screen-
ing of new therapeutics. Our Review focuses on gen-
eral principles, ideas, and caveats concerning the 
use of in vitro 3D model systems for studying tissue morphogenesis and tumorigenesis. We present recent 
examples chosen to illustrate key concepts. We also 
discuss exciting opportunities for further fundamental 
and translational research on cancer, stem cells, and 
tissue engineering.
Types of In Vitro 3D Models
One commonly used approach makes use of tissues har-
vested in vivo (microscopic embryonic organs or intact 
tissue slices), which are then explanted and cultured in 
vitro. They often retain their original 3D architecture in 
culture. This approach has been particularly effective in 
relatively short-term cultures for experimental analysis of 
numerous tissues including brain and embryonic glands 
(Gahwiler et al., 1997; Sakai et al., 2003). For most stud-
ies, the tissues must be thin enough to permit adequate 
oxygenation and nutrition of the tissue interior, e.g., less 
than ?0.3 mm thick. On the other hand, studies of tumor 
biology have benefited from systems that mimic the inter-
nal nutrient insufficiency of tumors to induce necrosis, 
which is important in studying tumor-host interactions 
such as the induction of tumor angiogenesis and resis-
tance to chemotherapeutic drugs (Hicks et al., 2006).
Many 3D models have been established starting from 
isolated cells, e.g., from cell lines, dissociated tissues, or 
stem cells. A widely used strategy is to propagate cells in 
tissue culture and then implant them in a 3D matrix scaf-
fold as either single cells or as tissue-like aggregates. 3D 
scaffolds have been generated from purified molecules 
such as collagen I, synthetic biomaterials, and even from 
native extracellular matrices from which living cells were 
previously extracted (Table S1). Another approach is to 
use more than one type of isolated cell or a tissue frag-
ment in combination with another cell type. An example 
of this is a 3D tissue model of human skin that combines 
keratinocytes and fibroblasts with cancer cells to simu-
late human melanoma (Smalley et al., 2006).Cell 130, August 24, 2007 ©2007 Elsevier Inc. 601
Table 1. Key Strengths and Weaknesses of 3D Models
Advantages
• Cell morphology and signaling are often more physiological than routine 2D cell culture
• Permit rapid experimental manipulations and testing of hypotheses
• Permit much better real-time and/or fixed imaging by microscopy than in animals
Disadvantages
• Vary in their ability to mimic in vivo tissue conditions
• Currently lack vasculature and normal transport of small molecules, host immune responses, and other cell-cell interactions
• Generally mimic static or short-term conditions, whereas in vivo systems often progressTable 1 lists major advantages and disadvantages 
of current 3D systems compared to regular cell culture 
and animal models. Comparisons of 2D and 3D models 
reveal that the latter are better, but not exact, models 
of in vivo tissues. Table 2 compares specific biological 
properties and their regulation in 2D and 3D systems, 
and details are presented in Tables S1 and S2. For exam-
ple, glandular epithelial cell organization, signaling, and 
secretion are more similar to what occurs in vivo in 3D 
settings than comparable 2D approaches (Debnath and 
Brugge, 2005; Nelson and Bissell, 2006). The morpholo-
gies of fibroblasts, including cytoskeletal organization 
and types of cell adhesions, are also more similar to their 
in vivo behavior when the fibroblasts are grown in a 3D 
matrix than when grown in 2D (Figure 1). This is also true 
of their intracellular signaling characteristics (Cukierman 
et al., 2001, 2002; Grinnell, 2003; Walpita and Hay, 2002). 
Studies of gene expression and mRNA splicing patterns 
also reveal considerable differences when cells are cul-
tured under 2D versus 3D conditions (Birgersdotter et 
al., 2005; Li et al., 2006).
Model Choice Affects Outcome
In any 3D model system, the specific cellular and matrix 
microenvironment provided to cells can substantially influ-
ence experimental outcome. For example, embedding 
tumor cells in a 3D collagen matrix as single cells, small 
aggregates, or larger aggregates can result, respectively, 602 Cell 130, August 24, 2007 ©2007 Elsevier Inc.in individual cell migration and invasion, collective cell inva-
sion, or mixtures of invasive and necrotic cells (Friedl, 2004; 
Mueller-Klieser, 1997). Because 3D in vitro model systems 
lack the complex vascular systems that perfuse tissues in 
vivo, oxygenation, nutrition, and waste removal occur by 
simple diffusion. Consequently, as the tissue thickness of 
a 3D model increases, transport limitations for these mol-
ecules will become increasingly important. Although nutri-
ent restrictions may sometimes mimic in vivo tissue and 
tumor microenvironments better than the uniformly rich 
oxygenation and nutrition provided to monolayer cells in 
2D cultures, they also introduce significant and potentially 
confounding variables to 3D models. This is because cells 
at different depths from the surface can be in different nutri-
tional states (Keith and Simon, 2007; Levenberg, 2005).
In addition, both the composition and stiffness of the 
extracellular matrix surrounding the cells have major 
effects on cell signaling and behavior (Cukierman et al., 
2002; Discher et al., 2005; Grinnell, 2003; Paszek et al., 
2005). For example, collagen gels can mimic loose or 
dense connective tissue depending on the concentration 
of collagen; such gels have been used widely in studies 
of fibroblast and tumor cell migration and signaling (Grin-
nell, 2003). For growth and differentiation of epithelial 
cells, however, reconstituted gels of an extract contain-
ing basement membrane components and growth fac-
tors termed Matrigel (or EHS matrix or Cultrex) are much 
more effective (Kleinman and Martin, 2005). 3D matrices Table 2. 3D-Dependent Cell Behavior and Signaling
Biological Function 2D versus 3D Regulatory Mechanisms
Cell Shape Loss of epithelial cell polarity and altered 
epithelial and fibroblast shape in 2D
Growth factor receptors and pathways; cell-adhesion sig-
nals associated with cell survival and matrix plasticity
Gene Expression Cells in 2D versus 3D often have different 
patterns of gene expression 
ECM, hormones, and adhesion molecules
Growth 3D matrix-dependent regulation of cell 
growth
Adhesion and growth factor-related pathways plus survival 
or apoptotic genes
Morphogenesis 3D matrix-induced vessel sprouting and 
gland branching
ECM, adhesion, growth factor-related pathways and apop-
totic genes
Motility Altered single and collective cell motility  
patterns in 3D matrices
ECM and its regulators; adhesions and growth factor-re-
lated pathways; phospholipids
Differentiation 3D matrix-induced cell differentiation ECM and growth factors; motor molecules
See Table S2 for references and additional information.
generated by cells in vitro provide yet another class of 
matrix (Cukierman et al., 2001). Each type of matrix can 
also have experimental drawbacks. For example, colla-
gen gels lack other components of connective tissue, 
and they differ in the extent of covalent crosslinking. 
Matrigel consists of basement membrane components, 
but it is a 3D cell culture material rather than a mimetic 
of the flat basement membranes underneath cells. 
Finally, cell-derived matrices can have lower amounts 
of collagen, larger internal spaces, and less depth than 
mature tissue matrices. Thus, an important point is that 
because each tissue in vivo has a characteristic matrix 
microenvironment, for a given study it is crucial to select 
an appropriately matched 3D in vitro matrix.
Matrix Stiffness
Although the molecular composition of the extra-
cellular matrix is a well-known regulator of cellular 
responses, physical properties of the matrix in 3D 
models can also play surprisingly important roles. In 
particular, recent evidence points to direct roles for 
the stiffness (compliance) of the extracellular matrix 
in regulating multiple cellular functions (Discher et al., 
2005; Paszek et al., 2005; Pelham and Wang, 1997). 
This property, also described as rigidity, elasticity, 
or pliability, is sensed by cells through bidirectional 
interaction between cells and the surrounding extra-
cellular matrix. Cell surface integrin receptors and the 
contractile cytoskeleton pull against the extracellular 
matrix to sense the stiffness of the microenvironment 
(Ghosh et al., 2007; Ingber, 2006; Vogel and Sheetz, 
2006). Biologically, cells need to sense and respond 
appropriately to their local microenvironment. The 
stiffness of microenvironments is variable; examples 
include loose versus dense connective tissue, soft 
versus hard tissues (such as bones and teeth), and 
early versus late stages of wound healing.
The stiffness of a matrix and its susceptibility to 
remodeling by cellular contractile processes, matrix 
secretion, and enzymatic degradation can affect the 
distribution of cell surface integrin 
receptors and the types of cell adhe-
sions and cytoskeletal structures 
formed (Cukierman et al., 2001; Katz 
et al., 2000; Walpita and Hay, 2002). 
Matrix stiffness also alters intracellu-
lar signaling via Rho kinase and Rac 
(Pankov et al., 2005; Paszek et al., 
2005; Wozniak et al., 2003). Stiffness 
can also enhance cell proliferation, in some cases 
promoting neoplasia (Paszek et al., 2005; Pelham and 
Wang, 1997).
Different in vitro 3D models provide a range of matrix 
stiffness that can mimic the range found in specific 
tissues in living organisms. Wide differences in stiff-
ness exist between soft adipose tissue and the tightly 
woven basement membrane (such as encountered by 
mammary epithelial cells), as well as between loose 
matrices used by cells for migration during embryogen-
esis, dense connective tissue in skin, and precalcified 
osteoid versus rigid mature bone (Discher et al., 2005; 
Engler et al., 2006; Paszek et al., 2005). Pathologi-
cal processes such as fibrosis or microenvironmental 
changes within and around developing tumors can also 
alter tissue stiffness and cellular responses (Engler et 
al., 2004). For example, dense, nonpliable desmoplastic 
tissue is associated with some carcinomas (Paszek et 
al., 2005) and sites predisposed for secondary metas-
tases (Kaplan et al., 2005).
Cell and Tissue Polarity
Another critical in vivo property provided by 3D mod-
els is appropriate cell polarity. Polarity in vivo depends 
both on the cell type and the cellular microenviron-
ment (Figure 2). Epithelial cells are often polarized, 
with apical and basal surfaces that are important for 
tissue organization and directional secretion of prod-
ucts. Their basal surfaces rest on thin, flat basement 
membranes comprised of collagen IV, laminin, and 
many other matrix proteins. In many tissues, particu-
larly secretory organs, epithelial cells are organized 
into spherical 3D structures surrounding a lumen to 
function as acini of glands, alveoli (lung), or glomeruli 
(kidney). Tissue organization is lost when these cells 
are explanted onto flat 2D tissue culture substrates, 
and this organization and differentiated function can 
be restored or maintained when the cells are placed 
into 3D culture conditions (Griffith and Swartz, 2006; 
Nelson and Bissell, 2006).
Figure 1. Human Fibroblasts in 2D versus 
3D Microenvironments
Cells were cultured on planar fibronectin (left pan-
el) or within a mesenchymal cell-derived three- 
dimensional (3D) matrix (right panel). Note the 
striking differences in overall morphology, fibro-
nectin matrix organization (blue), and architecture 
of α5 integrin-positive adhesion structures (white); 
nuclei are magenta. Scale bar = 10 µm.Cell 130, August 24, 2007 ©2007 Elsevier Inc. 603
Because basement membranes are thin and basi-
cally 2D, epithelial cells in vivo resting on a flat base-
ment membrane can be considered to be adhering to 
a 2D substrate (Figure 2). We predict, therefore, that it 
should eventually be possible to elicit normal, differen-
tiated epithelial cell function on appropriately designed 
2D surfaces in vitro, e.g., with a composition and stiff-
ness mimicking basement membranes when combined 
with soluble stromal factors.
In direct contrast, cells such as fibroblasts lack this 
highly polar apical-basal organization in vivo. However, 
when placed onto 2D culture substrates, these cells 
acquire an upper (dorsal) and lower (ventral) surface, 
and prominent cell adhesions to the substrate form on 
the ventral surface. Fibroblasts lose this artificial dor-
sal-ventral polarity when placed back into a mesenchy-
mal 3D matrix, and they regain their in vivo morphology 
(Amatangelo et al., 2005; Cukierman et al., 2001; Grin-
nell, 2003). Three-dimensionality per se—independent 
of matrix composition—can physiologically reprogram 
fibroblasts. There are striking differences in morphology, 
proliferation, and directionality of migration between cells 
cultured on a 3D matrix versus cells cultured on a matrix 
of identical biochemical composition that has been flat-
tened to provide a 2D surface (Cukierman et al., 2001; 
Pankov et al., 2005; Zaman et al., 2006). One explanation 
for this may involve cellular detection of matrix contact 
with both ventral and dorsal surfaces. Simply bring-
ing a collagenous substrate into contact with both cell 
surfaces restores more normal 3D morphology in fibro-
blasts (Beningo et al., 2004); however, whether other cell 
functions such as signaling and proliferation are similarly 
regulated remains to be examined.
Taken together, studies of epithelial cells and fibro-
blasts indicate that an important feature of 3D mod-
els is their ability to mimic normal tissue organiza-
tion to induce appropriate polarity of each cell type 
(Figure 2). Nevertheless, polarity and phenotype are 
not always fixed; at specific stages of 
embryonic development and in some 
cancers, epithelial cells can undergo 
an epithelial-to-mesenchymal transi-
tion involving the loss of cell-cell adhesions and polar-
ity, accompanied by activation of cell migration (Hay, 
2005; Thiery and Sleeman, 2006).
3D Models in Developmental Biology
Morphogenesis—the development of form in the 
embryo—has recently been analyzed extensively in a 
variety of 3D model systems, particularly organ cultures 
and cell line models. A major goal in embryology has 
been to understand the mechanisms and regulation of 
branching morphogenesis (Figure 3), a process essential 
for the formation of glands and organs, including lungs, 
kidneys, salivary and mammary glands, prostate, and 
the vasculature (Affolter et al., 2003; Monte et al., 2007; 
Patel et al., 2006; Sternlicht et al., 2006). This complex 
process involves a daunting number of transcription fac-
tors, growth factors, and receptors (Monte et al., 2007; 
Patel et al., 2006).
In order to understand the key steps and physical 
mechanisms of branching morphogenesis, organ cultures 
of early glands have provided invaluable 3D models. Iso-
lated epithelium stripped of its surrounding mesenchymal 
tissue can continue to undergo branching if provided with 
appropriate growth factors and extracellular matrix sup-
port. In fact, embryonic lung and salivary gland epithelia 
can be dissociated into single cells, which can reaggre-
gate and regenerate branched organoids in an appropri-
ate 3D microenvironment. Established epithelial cell lines 
such as Madin-Darby canine kidney (MDCK) cells have 
also been used (Mondrinos et al., 2006; Wei et al., 2007).
The steps in morphogenesis can then be analyzed in 
depth using tissue culture approaches that include anti-
body inhibition, regulation by exogenous proteins (e.g., 
growth factors and matrix proteins), cDNA overexpres-
sion, and gene knockdown by RNA interference. Recent 
findings that could not have been established without 
3D models of embryonic acinus formation and branch-
ing morphogenesis include the importance of Cdc42, 
Figure 2. Cell and Tissue Organization in 
2D versus 3D
Cells explanted into routine tissue cultures often 
flatten and lose differentiation markers. When 
placed back in appropriate 3D culture condi-
tions, epithelial cells generally regain apical-
basal polarity, and glandular cells form a lumen 
into which differentiated products are secreted. 
The inset image shows the morphology of hu-
man salivary gland cells reaggregated in vitro. In 
contrast, mesenchymal derivatives in 3D (lower 
right) regain a fibroblastic spindle shape and lose 
their artificial dorsal-ventral polarity. Epithelial 
cells often rest on a relatively thin 2D basement 
membrane facing a lumen. They can sometimes 
undergo an epithelial-mesenchymal transition to 
become migratory in a 3D stroma.604 Cell 130, August 24, 2007 ©2007 Elsevier Inc.
PTEN, and differential phosphoinositide localization 
for determining apical-basal polarity of epithelial cells 
(Tables 2 and S2; Martin-Belmonte et al., 2007). Other 
intriguing findings coming from the use of 3D organ 
culture models include identification of mechanisms of 
growth factor signaling, the observation of vigorous ran-
dom cell migration of epithelial cells during branching 
morphogenesis, and a previously unsuspected role for 
the matrix protein fibronectin in driving epithelial branch-
ing (Costantini, 2006; Larsen et al., 2006b; Monte et al., 
2007; Patel et al., 2006; Sakai et al., 2003).
3D models are also making important contributions 
to our growing appreciation of mechanobiology, includ-
ing the responses of bone, blood vessels, and connec-
tive tissue to mechanical forces. Numerous studies have 
analyzed the bidirectional mechanosensory responses of 
fibroblasts or myofibroblasts to collagen gels (Cukierman 
et al., 2002; Discher et al., 2005; Ghosh et al., 2007; Grin-
nell, 2003; Orr et al., 2006). For example, cellular signaling 
differs depending on whether the gel is under tension or 
free floating and compliant (Grinnell, 2003). Conversely, 
extracellular matrices are actively remodeled by fibro-
blastic cells by synthesis, degradation, and contraction, 
thereby altering their mechanical effects on cells (Grin-
nell, 2003; Larsen et al., 2006a). Experimental manipu-
lation of cell interactions with 3D matrix models should 
provide new opportunities for evaluating the mechanisms 
of mechanochemical signaling, including the study of the 
interactions of integrin binding to the matrix and the regu-
lation of the cytoskeleton, kinases, and stretch-sensitive 
ion channels (Griffith and Swartz, 2006; Orr et al., 2006).
Stem Cells in 3D
Determining the factors that regulate stem cell fate will 
provide tools for controlling their differentiation in poten-
tial clinical applications. In addition to responding to 
growth factors, retinoic acid, and other soluble regula-
tors (Chen et al., 2003; Griffith and Swartz, 2006), stem 
cells can be regulated by three-dimen-
sionality. Cultured stem cells self-
assemble into embryoid bodies that 
mimic the inner cell mass of embryos. 
These 3D embryoid bodies have been 
used for numerous studies, provid-
ing insights into mechanisms underly-
ing cell polarity (Yang et al., 2007) and 
revealing the roles of laminin and integrins in the forma-
tion of the basement membrane (Li et al., 2002).
Recent efforts have sought to identify optimal 3D 
matrices for stem cell maintenance or differentia-
tion (Table S1). For example, in 3D collagen matrices 
embryonic stem cells can differentiate into epithelial 
and other lineages; coculture of embryonic stem cells 
with fibroblasts promotes a neural lineage, whereas 
coculture with keratinocytes promotes endothelial dif-
ferentiation (Chen et al., 2003). Conversely, forcing 
human embryonic stem cells to grow as 2D cultures 
instead of embryoid bodies stimulates their subse-
quent differentiation, in one case into blood vessels 
(Wang et al., 2007).
As with other cells, stem cell fate and differentia-
tion can also be altered by varying the stiffness of 
the substrate. The ability of stem cells to undergo 
neuronal, myoblastic, or osteogenic differentiation is 
strikingly altered by substrate stiffness (Engler et al., 
2004, 2006), providing a potentially powerful physi-
cal means of altering stem cell fate for potential clini-
cal application.
3D Models of Cancer Growth and Metastasis
The mechanisms of aberrant proliferation and invasion 
in cancer have been analyzed fruitfully in 3D model sys-
tems (Bissell and Labarge, 2005; Debnath and Brugge, 
2005; Kim, 2005). As discussed below, systems have 
ranged from single cells to tumor spheroids and acinar 
models probed by genetic, chemical, and immunologi-
cal approaches.
Tumor Proteases and Invasion
At the single-cell level, local cleavage of the surround-
ing matrix by transmembrane proteases of the mem-
brane type matrix metalloproteinases (MT-MMP) family is 
required for cell proliferation in model tumors and integrin-
mediated invasion into collagen gels (Hotary et al., 2006). 
Proteolysis of 3D crosslinked collagen, which surrounds 
Figure 3. Branching Morphogenesis of 
Epithelial Organs
Branching of epithelial organs such as these 
salivary glands is essential for rapidly generating 
a large functional surface area, as shown here 
between embryonic days 12 and 15 of mouse 
development (upper panels). Branching mor-
phogenesis of these and other glands can be 
studied readily in 3D organ culture, as shown in 
the lower panels spanning 72 hr in vitro (modi-
fied from Sakai et al., 2003). All images in the 
upper or lower panels are at the same magnifi-
cation; scale bars = 100 µm.Cell 130, August 24, 2007 ©2007 Elsevier Inc. 605
and imprisons the cells, facilitates their release. Similarly, 
MT1-MMP allows the expansion of normal endothelial 
cells to form new blood vessels and promotes the dif-
ferentiation of preadipocytes into white adipocyte tissue 
(Chun et al., 2006). However, in seemingly conflicting find-
ings, experimental blockade of all extracellular proteases, 
including MMPs, was reported to have no effect on cell 
invasion in another 3D collagen gel system; instead, tumor 
cells switched to an ameboid type of migration analogous 
to that used by T cells, which does not require integrins 
and uses different Rho-ROCK signaling (Friedl, 2004; 
Wyckoff et al., 2006). These conflicting conclusions con-
cerning requirements for proteases in tumor cell invasion 
may be explained by the different 3D collagen gels used 
for assays, such as different extent of crosslinking or pore 
size. This discrepancy is important to resolve concerning 
potential therapeutic targeting of specific proteases.
Spheroid Models
In vitro aggregates of embryonic cells have been stud-
ied for decades to understand the principles of morpho-
genesis and tissue formation. These aggregates, called 
“spheroids,” often consist of stem cells or tumor cells 
from malignant cell lines or fragments of human tumors 
(Kunz-Schughart et al., 2004; Mueller-Klieser, 1997; 
Wartenberg et al., 2001). Spheroids can be studied in 
suspension in hanging drops of medium, in bioreactors, 
or in 3D matrices, and they can be established from a 
single cell type or can be multicellular mixtures of tumor, 
stromal, and immune cells. These aggregates can mimic 
tumor behavior more effectively than regular 2D cell 
cultures because spheroids, much like tumors, usually 
contain both surface-exposed and deeply buried cells, 
proliferating and nonproliferating cells, and well-oxy-
genated and hypoxic cells (the latter secreting tumor cell 
cytokines; Frieboes et al., 2006). Homogeneous popula-
tions of spheroids may prove valuable for high-through-
put drug screening (Kunz-Schughart et al., 2004).
Spheroids can also be used to study the adhesive prop-
erties of tumor cells (Winters et al., 2005), and their behav-
ior can be analyzed by computational modeling (Frieboes 
et al., 2006). Interactions between different cell types can 
also be analyzed in spheroids; for example, tumor-induced 
angiogenic responses can be modeled using cultures in 
which tumor spheroids interact with vascular cells gener-
ated from embryonic stem cells (Wartenberg et al., 2001).
Tissue Architecture and Signaling in Cancer
In addition to oncogenic mutations, common features of 
neoplasia include aberrant tissue organization and signal 
transduction. Recent studies using 3D in vitro models have 
shown that the interdependent balance of activities of inte-
grins, growth factor receptors, and intracellular signaling 
distinguishes malignant from normal tissue architecture. 
Human 3D in vitro epithelial models of mammary acini can 
mimic the increasingly abnormal tissue organization char-
acteristic of breast carcinoma progression, where tumor 
cells suppress normal apoptotic mechanisms to invade 
the lumen (Debnath and Brugge, 2005; Wang et al., 1998). 
Polarity also plays a role because oncogene-induced dis-606 Cell 130, August 24, 2007 ©2007 Elsevier Inc.ruption of acinar architecture by ErbB2 requires interaction 
with the Par polarity complex components Par6 and aPKC 
(atypical protein kinase C). This interaction between onco-
gene and polarity signaling induces acinar disruption while 
suppressing apoptosis independently from oncogene 
stimulation of proliferation (Aranda et al., 2006).
Remarkably, individually inhibiting the function of β1 
integrin, EGF receptor, MAP kinase, PI 3-kinase, or Par6 
can restore acinar architecture to a state closer to normal, 
even though genomic abnormalities persist (Aranda et al., 
2006; Liu et al., 2004; Wang et al., 1998). These findings 
reveal an interwoven system regulating tissue organiza-
tion. Conversely, protease disruption of extracellular matrix 
organization can sometimes lead to carcinogenesis via a 
pathway involving the GTPase Rac1b and reactive oxygen 
species (ROS) leading to genomic instability (Radisky et 
al., 2005). These studies show crucial roles for cell-matrix 
interactions and tissue architecture in cancer. In addition, 
analyzing patterns of gene expression in 3D in vitro mam-
mary acini may be useful for predicting breast cancer out-
come (Bissell and Labarge, 2005; Fournier et al., 2006).
Microenvironment and Stroma
Tumorigenesis is akin to a developmental process in which 
the interaction between pluripotent stem cells within the 
tumor and the local microenvironment determines the 
success or suppression of tumorigenesis (Beacham and 
Cukierman, 2005; Bissell and Labarge, 2005; Mintz and Ill-
mensee, 1975). Gene expression is selectively altered in the 
tumor microenvironment (Allinen et al., 2004), and specific 
stromal factors can promote tumor growth and angiogen-
esis (Bissell and Labarge, 2005; Orimo et al., 2005). In fact, 
secondary niches that are preconditioned by changes that 
make them similar to tumor stroma can serve as sites for 
homing of metastasizing cells. For example, myofibroblasts 
can deposit a fibronectin-rich matrix to create a favorable 
environment for incoming tumor cells (Kaplan et al., 2005). 
The tumor microenvironment can mimic aspects of wound 
healing, and tumor factors induce a “primed” stroma that 
can in turn promote tumor initiation or progression. Fur-
ther stromal alteration via immune responses and other 
processes results in a characteristic “activated” stroma 
with high rates of proliferation and abnormal production 
of matrix and matrix proteases (Beacham and Cukierman, 
2005; Birgersdotter et al., 2005). In 3D models, tumor cells 
respond to this matrix with Rho-dependent cytoskeletal 
contractility that promotes focal adhesions, hinders epi-
thelial polarity and lumen formation, alters differentiation, 
and promotes growth via ERK, Rho, and Rho kinase sig-
naling (Paszek et al., 2005; Wozniak et al., 2003).
Future Applications
We emphasize that in vitro 3D tissue models are experi-
mental tools. Although some 3D models make use of 
intact tissues, embryonic organs, or reconstituted mimics 
of living tissues, they are not intact animals and for that 
reason do not reproduce all of the normal microenviron-
mental inputs depicted in Figure 4. For example, transport 
limitations of oxygen, other nutrients and pH can become 
important in these avascular models. As such, 3D sys-
tems must be considered models, and conclusions from 
their use may require further testing in vivo. Nevertheless, 
they provide potentially powerful tools for new applica-
tions represented by the following examples.
Prediction of In Vivo Outcomes
3D models provide systems for in-depth analyses of 
biological mechanisms. In addition to direct analysis 
and testing of hypotheses, they can provide an effi-
cient way to probe the function of candidate genes and 
proteins before proceeding to laborious gene targeting 
approaches in animals. For example, projects involving 
analysis of gene expression commonly identify hun-
dreds of candidate genes that might mediate a particular 
cellular process. 3D models can allow investigators to 
screen their functions in vitro to determine which genes 
are most interesting for further in vivo study.
In addition, 3D models based on human cells can 
potentially provide new systems for high-throughput 
chemical genomics and therapeutics screening (Khadem-
hosseini et al., 2006; Kunz-Schughart et al., 2004; Langer 
and Tirrell, 2004). Because rodents or other animals can 
metabolize and respond to drugs differently than humans 
(Rangarajan et al., 2004), using human 3D tissue surro-
gates for “in vivo-like” drug testing might help reduce the 
high failure rate in the development of new drugs. It might 
also be possible to use 3D models for individualized ther-
apy—that is, to predict the responsiveness of a particular 
patient’s tumor to chemotherapy or radiotherapy. Human 
3D tissue models can also provide systems for analyzing 
the pathogenesis of diseases, including cancer and vari-
ous genetic disorders. Although iterative in vivo validation 
of hypotheses remains the “gold standard,” 3D models 
can accelerate the process by quickly identifying the 
most promising targets and establishing mechanisms.
Multiparameter Quantitative Systems Analyses
Because 3D models are in vitro, experimenters can con-
trol and vary each of any number of parameters to gener-
ate quantitative data for systems analysis. For example, 
model tissues can be assayed for changes in gene and 
protein expression after systematically altering levels of 
growth or differentiation factors and/or nutrients in any 
combination and temporal sequence. Although many 
such studies have been performed on 
cells grown as monolayers, 3D models 
are likely to provide data with greater 
physiological relevance for mathemati-
cal models of growth, signaling, migra-
tion/invasion, and morphogenesis 
(Hicks et al., 2006; Nelson and Bissell, 
2006; Zaman et al., 2006). They can also provide a bridge 
between cell culture and in vivo modeling of developmen-
tal pattern formation (Khademhosseini et al., 2006; Langer 
and Tirrell, 2004; Reeves et al., 2006). In addition to test-
ing roles of diffusible regulatory factors, it should be pos-
sible to measure quantitatively the effects of changing the 
3D matrix scaffold, altering cell adhesions, or introducing 
additional cell types such as immune cells. Such studies 
tracking multiple parameters under many conditions are 
impractical in vivo, and they can permit development of 
sophisticated models in quantitative biology.
Determining the Role of Stroma in Carcinogenesis
Now that it is clear that the stroma can play important roles 
in supporting or even inducing tumorigenesis, the specific 
roles of stroma in tumor development, progression, local 
invasion, and homing to specific secondary sites need elu-
cidation. 3D systems should help dissect these processes 
in the tumor microenvironment that interact with, and are 
modified by, cancer stem cells. Although the primary focus 
of chemotherapeutic drug development has been on the 
tumor cells, new insight into the importance of the stroma 
in tumor progression argues for analyses in systems con-
taining both tumor and tumor stroma. Interactions with the 
stroma may influence drug sensitivity and development of 
drug resistance, which can be tested in 3D models.
Tissue Engineering and Stem Cells
The rapidly expanding field of bioengineering of 3D tissues 
will be a particularly active interface between in vitro stud-
ies and the clinic (Griffith and Swartz, 2006; Langer and 
Tirrell, 2004; Lutolf and Hubbell, 2005). A major strategy 
involves developing artificial mimetics of matrix molecules, 
which could ideally provide structural support, appropri-
ate integrin signals, and growth factor-binding functions of 
native extracellular matrix (Matsumoto and Mooney, 2006). 
An impressive range of 3D biomaterials, including synthetic 
polymers that self-assemble, are now available (Table S1). 
The ongoing empirical testing of these new scaffolds (both 
synthetic and containing reconstituted matrix molecules) 
for induction and maintenance of specific tissue pheno-
types represents one area of rapid progress.
Because stem cell fate can be regulated by matrix 
stiffness (Engler et al., 2006), the manipulation of matrix 
stiffness and crosslinking to alter human stem cell dif-
Figure 4. Microenvironmental Factors Af-
fecting Cell Behavior
Numerous aspects of the microenvironment that 
change spatially and temporally may affect how 
accurately a 3D model reflects cellular behavior 
in vivo. Conversely, cells (center) can actively 
modify their local microenvironment.Cell 130, August 24, 2007 ©2007 Elsevier Inc. 607
ferentiation pathways is another area poised for future 
advances. These efforts may lead to additional insight 
into the factors that promote normal differentiation 
or into the processes by which stroma stimulate self-
renewing cancer stem cells. A useful advance would 
be new methods to control stiffness without changing 
matrix density, i.e., without changing the concentration 
of sites bound by integrin adhesion receptors as occurs 
currently when the concentration of ligands (such as 
collagen) is increased to increase stiffness. Although 
stiffness can be controlled by crosslinking polyacryl-
amide gels (Pelham and Wang, 1997), alternative meth-
ods using biocompatible materials and natural reagents 
such as transglutaminase or chemical crosslinkers are 
needed to produce nontoxic implantable gels. However, 
because the range of changes in biomaterial stiffness is 
limited compared to the many possible stem cell phe-
notypes, this parameter will provide only one of multiple 
inputs to the cells (Figure 4). Nevertheless, advances in 
precisely controlling matrix stiffness will also advance 
fundamental research on mechanisms of matrix-medi-
ated mechanotransduction and cytoskeletal regulation.
Organization into Tissues
Current research is focusing intensely on controlling 
stem cell differentiation, but another major challenge 
involves integrating the cells into functional tissue struc-
tures. One approach could be to intercalate stem cells 
into damaged tissue, but the local environment may not 
sustain normal biological function if it is pathological 
(for example, if it is fibrotic; Engler et al., 2004). A major 
challenge will be to establish the appropriate topological 
interactions and spatial organization of cells into acini 
of glands, islets, ducts, or other morphological patterns 
(Khademhosseini et al., 2006; Langer and Tirrell, 2004). 
An additional important in vivo feature that can be mod-
eled in vitro is the effect of a second or third cell type 
on developmental fate and morphogenesis through cell-
cell and cell-matrix interactions. One example of this is 
the role that extracellular matrix deposited by fibroblasts 
has in facilitating angiogenesis (Berthod et al., 2006).
Although a goal of tissue engineering is to develop 
well-defined biomaterials and cells for replacing defec-
tive tissues, an important potentially confounding ele-
ment involves the secretory responses of cells to these 
materials and their microenvironment. Cells continually 
secrete complex mixtures of extracellular matrix pro-
teins and other regulators of cell behavior, which may 
affect what happens when exogenous cells or materials 
are implanted. For example, embryonic stem cells may 
generate their own microenvironmental niches when 
cultured in collagen or matrices from extracted tis-
sue (Postovit et al., 2006b). Cellular responses to local 
mechanical stresses and hypoxia need to be incorpo-
rated into existing 3D models to make them more real-
istic. 3D models also need to take dynamics within tis-
sues into account, such as interstitial fluid flow and local 
chemotactic gradients (Griffith and Swartz, 2006). An 
important general function of the extracellular matrix is 608 Cell 130, August 24, 2007 ©2007 Elsevier Inc.to serve as a reservoir for growth factors and cytokines. 
Matrix engineering can provide site-specific delivery of 
growth factors (Lutolf and Hubbell, 2005; Matsumoto 
and Mooney, 2006), though a challenge will be to ensure 
long-term function in vivo of these implanted materials.
Another focus of research will be on ways to manipu-
late cells prior to implantation, through partially differen-
tiating or genetically engineering cells in 2D or 3D set-
tings, especially for stem cells. Another major challenge 
involves linking vasculature to engineered tissues; fur-
ther studies of angiogenesis in 3D models may provide 
approaches to this difficult problem (Jakobsson et al., 
2007; Laschke et al., 2006).
Conclusions
The goals of researchers attempting to engineer func-
tional tissues for implantation in patients, clinicians 
interested in developing human tissue models for test-
ing drugs, and investigators probing the basic mecha-
nisms of morphogenesis, differentiation, and cancer 
frequently intersect at 3D in vitro models. These models 
provide a bridge between simple cell cultures and ani-
mals, though many parameters need to be considered 
(Figure 4). Studies with 3D model systems have repeat-
edly identified complex interacting roles of matrix stiff-
ness and composition, integrins, growth factor recep-
tors, and signaling in development and cancer. These 
insights suggest that plasticity, regulation, and sup-
pression of these processes can provide strategies and 
therapeutic targets for future cancer therapy and stem 
cell engineering (Bissell and Labarge, 2005; Postovit et 
al., 2006a). Besides providing model systems for testing 
ideas and potential therapeutic interventions, they may 
also permit high-throughput drug screening on human 
tissues in vitro. Insights from 3D in vitro systems into the 
mechanisms and regulation of morphogenesis, stem cell 
differentiation, and cancer should continue to crossfer-
tilize these fields.
Supplemental Data
Supplemental Data include two tables and References and can be 
found with this article online at http://www.cell.com/cgi/content/
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